The estimated Net Worth of Michael Geraghty is at least $165 millier dollars as of 6 June 2023. Mr. Geraghty owns over 10,000 units of Apyx Medical stock worth over $34,650 and over the last 9 years he sold APYX stock worth over $0. In addition, he makes $129,868 as Independent Director at Apyx Medical.
Michael has made over 4 trades of the Apyx Medical stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 10,000 units of APYX stock worth $27,900 on 6 June 2023.
The largest trade he's ever made was exercising 10,000 units of Apyx Medical stock on 6 June 2023 worth over $27,900. On average, Michael trades about 1,964 units every 59 days since 2015. As of 6 June 2023 he still owns at least 27,500 units of Apyx Medical stock.
You can see the complete history of Mr. Geraghty stock trades at the bottom of the page.
Michael E. Geraghty serves as Independent Director of the Company. He has served as a director since March 2011 and was previously employed as the President of Global Sales at Optos, Inc., a developer and manufacturer of retinal imaging devices for screening, detection and diagnosis of eye related conditions. From 2005 through 2008, he was the President of International Sales at Gyrus Acmi where he first started in 2000 as Senior Vice President of Sales for Gyrus Medical. Prior to this, Mr. Geraghty was the Vice President of Sales and Marketing for Everest Medical, Inc. and before that was the Director of Marketing for Advanced Products at Arthrocare Corporation. Mr. Geraghty specializes in building independent direct sales teams in the medical device industry and has extensive domestic and international sales and marketing experience. He received his bachelor’s degree from St. Mary’s University and graduate degree in Executive Sales Management from the University of Minnesota. The Company believes Mr. Geraghty is qualified to serve as Director and Compensation Committee Chair because of his extensive domestic and international sales, marketing, and management experience.
As the Independent Director of Apyx Medical, the total compensation of Michael Geraghty at Apyx Medical is $129,868. There are 11 executives at Apyx Medical getting paid more, with Charles Goodwin having the highest compensation of $1,945,260.
Michael Geraghty is 74, he's been the Independent Director of Apyx Medical since 2011. There are 1 older and 11 younger executives at Apyx Medical. The oldest executive at Apyx Medical Corporation is Andrew Makrides, 78, who is the Independent Chairman of the Board.
Michael's mailing address filed with the SEC is C/O APYX MEDICAL CORPORATION, 5115 ULMERTON ROAD, CLEARWATER, FL, 33760.
Over the last 6 years, insiders at Apyx Medical have traded over $0 worth of Apyx Medical stock and bought 97,836 units worth $253,260 . The most active insiders traders include Stavros G. Vizirgianakis, Charles D. Ii Goodwin et Moshe Citronowicz. On average, Apyx Medical executives and independent directors trade stock every 86 days with the average trade being worth of $18,719. The most recent stock trade was executed by Matthew C Hill on 13 August 2024, trading 5,336 units of APYX stock currently worth $6,030.
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and OEM. It offers electrosurgical generators based on its Helium Plasma Technology for cutting, coagulation, and ablation of soft tissue. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market that allows surgeons to operate with precision and eliminate unintended tissue trauma. It also develops, manufactures, and sells energy generators, disposable hand piece subassemblies, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Apyx Medical executives and other stock owners filed with the SEC include: